Renaissance Technologies (RenTech)'s PLRX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 2.05 M shares of Pliant Therapeutics, Inc. (PLRX) worth $2.34 M, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in PLRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 811,854 shares. Largest reduction occurred in Q3 2024, reducing 152,169 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Pliant Therapeutics (PLRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pliant Therapeutics (PLRX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +197,032 | Add 10.63% | 2.05 M | $1.14 |
| Q1 2026 | +807,024 | Add 77.17% | 1.85 M | $1.26 |
| Q4 2025 | +34,016 | Add 3.36% | 1.05 M | $1.22 |
| Q3 2025 | +811,854 | Add 406.03% | 1.01 M | $1.48 |
| Q2 2025 | +47,448 | Add 31.11% | 199,948 | $1.16 |
| Q1 2025 | +124,700 | Add 448.56% | 152,500 | $1.35 |
| Q4 2024 | -73,400 | Reduce 72.53% | 27,800 | $13.17 |
| Q3 2024 | -152,169 | Reduce 60.06% | 101,200 | $11.21 |
| Q2 2024 | +177,469 | Add 233.82% | 253,369 | $10.75 |
| Q1 2024 | +75,900 | New Buy | 75,900 | $14.90 |
| Q2 2023 | -138,200 | Sold Out | 0 | $0.00 |
| Q1 2023 | +117,400 | Add 564.42% | 138,200 | $0.03 |
| Q4 2022 | -73,500 | Reduce 77.94% | 20,800 | $0.02 |
| Q3 2022 | -10,800 | Reduce 10.28% | 94,300 | $20.89 |
| Q2 2022 | -500 | Reduce 0.47% | 105,100 | $8.01 |
| Q1 2022 | +75,293 | Add 248.43% | 105,600 | $7.01 |
| Q4 2021 | +307 | Add 1.02% | 30,307 | $13.50 |
| Q3 2021 | +30,000 | New Buy | 30,000 | $16.87 |
Renaissance Technologies (RenTech)'s Pliant Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Pliant Therapeutics, Inc. (PLRX) in Q3 2021, acquiring 30,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Pliant Therapeutics, Inc. (PLRX) for 18 quarters since Q3 2021.
Renaissance Technologies (RenTech)'s largest addition to Pliant Therapeutics, Inc. (PLRX) was in Q3 2025, adding 1,011,802 shares worth $1.5 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 2,049,874 shares of Pliant Therapeutics, Inc. (PLRX), valued at approximately $2.34 M.
As of the Q2 2026 filing, Pliant Therapeutics, Inc. (PLRX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Pliant Therapeutics, Inc. (PLRX) was 2,049,874 shares, as reported at the end of Q2 2026.